Please use this identifier to cite or link to this item:
https://cris.library.msu.ac.zw//handle/11408/5027
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Makuku, Rangarirai | - |
dc.contributor.author | Seyedmirzaei, Homa | - |
dc.contributor.author | Tantuoyir, Marcarious M | - |
dc.contributor.author | Rodríguez-Román, Eduardo | - |
dc.contributor.author | Albahash, Assil | - |
dc.contributor.author | Mohamed, Kawthar | - |
dc.contributor.author | Moyo, Ernest | - |
dc.contributor.author | Ahmed, Abdulrazaq Olamilekan | - |
dc.contributor.author | Razi, Sepideh | - |
dc.contributor.author | Rezaei, Nima | - |
dc.date.accessioned | 2022-08-02T17:58:23Z | - |
dc.date.available | 2022-08-02T17:58:23Z | - |
dc.date.issued | 2022-02-01 | - |
dc.identifier.issn | 1567-5769 | - |
dc.identifier.uri | https://doi.org/10.1016/j.intimp.2022.108580 | - |
dc.identifier.uri | http://hdl.handle.net/11408/5027 | - |
dc.description.abstract | According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), as of 2019, approximately 42.2 million people have died from acquired immunodeficiency syndrome (AIDS)-related illnesses since the start of the epidemic. Antiretroviral therapy (ART) has significantly reduced mortality, morbidity, and incidence of the human immunodeficiency virus (HIV)/AIDS-defining cancers, taming once-dreaded disease into a benign chronic infection. Although the treatment has prolonged the patients’ survival, general HIV prevalence has increased and this increase has dovetailed with an increasing incidence of Non-AIDS-defining cancers (NADCs) among people living with HIV (PLWH). This is happening when new promising approaches in both oncology and HIV infection are being developed. This review focuses on recent progress witnessed in immunotherapy approaches against HIV-related, Non-AIDS-defining cancers (NADCs), and HIV infection | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartofseries | International Immunopharmacology;Vol. 105, 108580 | - |
dc.subject | ART immunotherapy | en_US |
dc.subject | People living with HIV | en_US |
dc.subject | HIV | en_US |
dc.subject | Cancer | en_US |
dc.subject | CAR T cell therapy | en_US |
dc.title | Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article | en_US |
dc.type | Article | en_US |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
Appears in Collections: | Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
EXPLORING THE APPLICATION.pdf | Full-text | 729.92 kB | Adobe PDF | View/Open |
Items in MSUIR are protected by copyright, with all rights reserved, unless otherwise indicated.